CompletedPhase 4

Quality Assessment of Orotracheal Intubation Without Neuromuscular Blocking Agents in Obese Patients

France60 participantsStarted 2022-01-13

Plain-language summary

This study will assess the condition of orotracheal intubation in obese patients undergoing an elective bariatric surgery without the use of neuromuscular blocking agents. During the induction of general anesthesia, Propofol - Remifentanil combination will be used. The patients will be randomized in 2 groups with different doses of Remifentanil.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient over 18 and under 60 years old. * ASA score ≤ 3 * Elective bariatric surgery for patient with BMI between 35 and 60 or elective revision of a bariatric surgery for patient with a BMI over 30. * Patient with a written consent obtained with accurate information. Exclusion Criteria: * Patient with risk of aspiration * Difficult airway known (Cormack score 3 ou 4). * Opioids addiction. * Alcoholism * Chronic use of Opioids * Confirmed Allergy to Propofol or Remifentanil * Severe chronic hepatic, kidney or respiratory failure * Patient already enrolled in another clinical study interfering with this study.

What they're measuring

percentage of patients with excellent conditions of intubation

Timeframe: Baseline

Trial details

NCT IDNCT05026125

SponsorUniversity Hospital, Toulouse

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-11

View on ClinicalTrials.gov More Obesity trials